Freestone Capital Holdings LLC grew its holdings in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 6.3% during the second quarter, Holdings Channel.com reports. The firm owned 77,787 shares of the company’s stock after buying an additional 4,606 shares during the period. Freestone Capital Holdings LLC’s holdings in Procter & Gamble were worth $12,393,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Nova Wealth Management Inc. bought a new stake in shares of Procter & Gamble in the 1st quarter valued at approximately $26,000. Signature Resources Capital Management LLC grew its position in shares of Procter & Gamble by 67.9% in the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock valued at $28,000 after purchasing an additional 72 shares during the last quarter. Quarry LP acquired a new position in shares of Procter & Gamble during the first quarter worth approximately $33,000. Mid American Wealth Advisory Group Inc. acquired a new position in Procter & Gamble during the 2nd quarter valued at $34,000. Finally, RMG Wealth Management LLC acquired a new stake in Procter & Gamble during the second quarter worth about $37,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Insider Activity
In related news, CEO Gary A. Coombe sold 10,194 shares of the company’s stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the transaction, the chief executive officer owned 34,978 shares in the company, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Shailesh Jejurikar sold 13,039 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $2,050,643.53. Following the sale, the chief operating officer owned 28,036 shares of the company’s stock, valued at approximately $4,409,221.72. This represents a 31.74% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 150,488 shares of company stock valued at $23,529,718. 0.20% of the stock is owned by company insiders.
Procter & Gamble Stock Up 0.7%
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The firm had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. During the same quarter in the previous year, the firm earned $1.93 EPS. The business’s quarterly revenue was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be paid a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date is Friday, October 24th. Procter & Gamble’s dividend payout ratio is 61.61%.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on PG. Morgan Stanley set a $175.00 price objective on shares of Procter & Gamble in a research note on Monday, October 27th. Barclays reduced their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. BNP Paribas restated an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. UBS Group reduced their price objective on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Finally, Bank of America lowered their price target on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Twelve investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $171.53.
Get Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Why Are Stock Sectors Important to Successful Investing?
- 3 Safe and Steady Stocks for Any Market
- What is Forex and How Does it Work?
- Is Lemonade Stock Set for a Big Squeeze After Earnings?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Caterpillar Stock Could Top $650 by Year’s End
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
